Table 22.
Sixteen-Year Total Deaths, and Median survival in months with 95% Confidence Intervals for Selected Primary Malignant Brain and Other CNS Tumor Histologies, CBTRUS Statistical Report: NPCR, 2001–2017
| Histology | N | Deaths | Median Survival (95% CI) |
|---|---|---|---|
| Diffuse astrocytoma | 23,296 | 12,717 | 59 (57–62) |
| Anaplastic astrocytoma | 16,513 | 11,468 | 20 (19–21) |
| Glioblastoma | 133,975 | 119,145 | 8 (8-8) |
| Oligodendroglioma | 11,208 | 3,353 | 199 (190-**) |
| Anaplastic oligodendroglioma | 5,028 | 2,340 | 97 (91–107) |
| Oligoastrocytic tumors | 6,808 | 3,251 | 113 (108–121) |
| Pilocytic astrocytoma | 14,442 | 1,068 | ** (**-**) |
| Unique astrocytoma variants | 1,285 | 299 | ** (**-**) |
| Ependymal tumors | 10,950 | 2,300 | ** (**-**) |
| Glioma malignant, NOS | 19,031 | 8,967 | 93 (84–102) |
| Other neuroepithelial tumors | 174 | 53 | ** (137-**) |
| Neuronal and mixed neuronal-glial tumors | 2,337 | 735 | 190 (179-**) |
| Choroid plexus tumors | 359 | 136 | 176 (125-**) |
| Tumors of the pineal region | 1,031 | 360 | ** (146-**) |
| Embryonal tumors | 9,946 | 3,847 | ** (**-**) |
| Nerve sheath tumors | 669 | 233 | ** (**-**) |
| Meningiomas | 4,842 | 2,333 | 103 (94–110) |
| Mesenchymal tumors | 1,869 | 741 | 136 (118–148) |
| Primary melanocytic lesions | 159 | 118 | 15 (11–25) |
| Lymphoma | 18,327 | 12,396 | 15 (14–16) |
| Other hematopoietic neoplasms | 225 | 101 | 138 (87-**) |
| Germ cell tumors | 2,939 | 440 | ** (**-**) |
| Tumors of the pituitary | 402 | 134 | ** (165-**) |
| Neoplasm, unspecified | 10,276 | 8,332 | 3 (3-3) |
| All other | 176 | 97 | 23 (17–49) |
** cannot be calculated
Abbreviations: AYA, Adolescents and Young Adults; CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; SEER, Surveillance, Epidemiology, and End Results Program; CI, confidence interval; NOS, not otherwise specified